Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia

Methods Mol Biol. 2010:617:79-91. doi: 10.1007/978-1-60327-323-7_7.

Abstract

Pain-depressed behavior can be defined as any behavior that decreases in rate, frequency, duration, or intensity in response to a putative pain state. Common examples include pain-related decreases in feeding, locomotion and expression of positively reinforced operant behavior. In humans, depression of behavior is often accompanied by a comorbid depression of mood. Measurements of pain-depressed behaviors are used to diagnose pain in both human and veterinary medicine, and restoration of pain-depressed behavior is often a priority of treatment. This article describes two strategies for integrating measures of pain-depressed behaviors into preclinical assays of pain and analgesia. Assays of pain-depressed behaviors may contribute both to improved translational efficiency in analgesic drug development and to new insights regarding the mechanisms and determinants of pain and analgesia.

MeSH terms

  • Acetic Acid / pharmacology
  • Analgesia / methods*
  • Analgesics / therapeutic use*
  • Animals
  • Behavior, Animal / drug effects
  • Behavior, Animal / physiology*
  • Drug Evaluation, Preclinical / methods
  • Haloperidol / pharmacology
  • Haloperidol / therapeutic use
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Morphine / pharmacology
  • Morphine / therapeutic use
  • Narcotic Antagonists / pharmacology
  • Narcotic Antagonists / therapeutic use
  • Pain / chemically induced
  • Pain / drug therapy*
  • Pain / physiopathology*
  • Pain Measurement* / instrumentation
  • Pain Measurement* / methods
  • Rats
  • Self Stimulation

Substances

  • Analgesics
  • Narcotic Antagonists
  • Morphine
  • Haloperidol
  • Acetic Acid